This is an extension study only inviting subjects who have previously completed the RESTFUL Study (NCT04874155).~Each study subject is enrolled into one of the following Arms:~Arm 1 (Direct Roll-Over Extension): 24-week open-label NPNS followed by 8-weeks of no treatment, no delay after completion of the RESTFUL Study~Arm 2 (Control Group): 24-weeks of no treatment
Multi-center, prospective open-label extension study of noninvasive peripheral nerve stimulation (NPNS) with the NTX100 Neuromodulation System for patients with medication-refractory moderate- severe primary RLS